About Shandong Sinobioway Biomedicine Company

The company is a foreign-invested company limited by Zibo Wanchang Technology Development Co., Ltd. established on November 16, 2009 (now changed to a domestic enterprise) with the approval of the Shandong Provincial Department of Commerce with the approval of Yelu Business Foreign Investors [2009] No. 289. The company's stock was listed and traded on the SME board of the Shenzhen Stock Exchange on May 20, 2011. The company's business segments include biomedical segments such as interferons, nerve growth factors, vaccines and pharmaceutical intermediates. The company has important products including nerve growth factor products, mouse nerve growth factor for injection (trade name: Enjingfu), interferon products, human interferon α2b injections (trade name: amfulon), and human interferon α2b sprays (trade name: tactile). Corporate honors: High-tech Enterprise Certificate; Xiamen Bioengineering Technology Research Center; High-tech Achievements Fair Outstanding Product Award; Xiamen Independent Innovative Seed Enterprise; Fujian Excellent New Product; Fujian Innovative Pilot Enterprise; Green Development Zone, etc.